Serum hydrogen sulfide and outcome association in pneumonia by the SARS-CoV-2 coronavirus
…, K Katrini, C Damoulari, K Akinosoglou, C Psarrakis… - Shock, 2020 - journals.lww.com
Background: The pneumonia of COVID-19 illness has often a subtle initial presentation making
mandatory the use of biomarkers for evaluation of severity and prediction of final patient …
mandatory the use of biomarkers for evaluation of severity and prediction of final patient …
[HTML][HTML] Evolution of epidemiological characteristics of infective endocarditis in Greece
…, T Tsaganos, E Karofilakis, C Psarrakis… - International Journal of …, 2021 - Elsevier
Objective The clinical profile, management and outcome of infective endocarditis (IE) may be
influenced by socioeconomic issues. Methods A nationwide prospective study evaluated IE …
influenced by socioeconomic issues. Methods A nationwide prospective study evaluated IE …
Advancements in the pharmacological management of sepsis in the elderly
C Psarrakis… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Sepsis is a global health threat with high associated mortality especially among
the elderly. Population aging and sepsis have a tremendous negative impact on national …
the elderly. Population aging and sepsis have a tremendous negative impact on national …
[HTML][HTML] Evaluation of the Novel Sepsis Biomarker Host-Derived Delta-like Canonical Notch Ligand 1—A Secondary Analysis of 405 Patients Suffering from …
…, A Kotsaki, T Kanni, N Antonakos, C Psarrakis… - International Journal of …, 2023 - mdpi.com
Sepsis is defined as organ failure caused by dysregulated host response to infection. While
early antibiotic treatment in patients with acute infection is essential, treating non-infectious …
early antibiotic treatment in patients with acute infection is essential, treating non-infectious …
Preliminary data of a quantitative point of care test for SARS-CoV-2 antibodies from Greece
…, A Ploussi, N Pantazis, T Sirmpilantze, C Psarrakis… - in vivo, 2020 - iv.iiarjournals.org
Background: Antibody testing is necessary to identify immune individuals in the post-initial
wave of the COVID-19 pandemic. Patients and Methods: We prospectively evaluated the …
wave of the COVID-19 pandemic. Patients and Methods: We prospectively evaluated the …
[HTML][HTML] A cost of illness analysis of hepatocellular carcinoma for the Greek healthcare setting
…, F Pliarchopoulou, V Naoum, C Psarrakis… - … and Hepatology From …, 2020 - ncbi.nlm.nih.gov
Aim: To estimate the cost per patient for hepatocellular carcinoma in Greece, a setting that is
currently facing financial constraints. Background: Hepatocellular carcinoma patient …
currently facing financial constraints. Background: Hepatocellular carcinoma patient …
COVID-19: the day after
…, P Kazakou, S Grigoropoulou, C Psarrakis… - 2021 - Eur Respiratory Soc
Introduction: Patients recovering from pneumonia and ARDS may develop fibrotic changes.
Concerning COVID-19, there is evidence that residual persistent ground glass opacities and/…
Concerning COVID-19, there is evidence that residual persistent ground glass opacities and/…
[HTML][HTML] COVID-19 mortality risk assessment: An international multi-center study
D Bertsimas, G Lukin, L Mingardi, O Nohadani… - PloS one, 2020 - journals.plos.org
Timely identification of COVID-19 patients at high risk of mortality can significantly improve
patient management and resource allocation within hospitals. This study seeks to develop …
patient management and resource allocation within hospitals. This study seeks to develop …
[PDF][PDF] HELLENIC SEPSIS STUDY GROUP BOOKLET ON SEPSIS DEFINITIONS-DIAGNOSTIC APPROACH-TREATMENT RECOMMENDATIONS
E Team, EJ Giamarellos-Bourboulis, C Gogos… - sepsis.gr
The Hellenic Sepsis Study Group (HSSG) was formed in 2006 with the aim to resister the
epidemiology and particular pathogenetic aspects of sepsis in Greece. This effort is …
epidemiology and particular pathogenetic aspects of sepsis in Greece. This effort is …
[HTML][HTML] Real-World Data from the Use of Ranolazine in Patients with Stable Angina Pectoris: The RANGER Study
C Olympios, P Stafylas, A Dermitzakis… - Journal of Clinical …, 2024 - mdpi.com
Background: Although ranolazine has been available for years as a second-line treatment
to reduce angina attacks in patients with stable angina pectoris, real-world data on the …
to reduce angina attacks in patients with stable angina pectoris, real-world data on the …